LU92255I2
Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
Abstract
This record has no abstract on file.
Term
6.8 yearsto projected expiry
Projected expiry 17 July 2033, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
80 members in 16 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 43833199 | United States of America | A | |
| 43833199 | United States of America | A | |
| US19990438331 | – | – | – |
Members80
| Document | Office | Kind | |
|---|---|---|---|
| CA2389337A1 | Canada | A1 | |
| CA2389345A1 | Canada | A1 | |
| CA2389487A1 | Canada | A1 | |
| WO0136608A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO0136609A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO0136611A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1602501A | Australia | A | |
| AU3072401A | Australia | A | |
| AU3643601A | Australia | A | |
| WO0136608A8 | World Intellectual Property Organization (WIPO) | A8 | |
| WO0136609A8 | World Intellectual Property Organization (WIPO) | A8 | |
| WO0136611A8 | World Intellectual Property Organization (WIPO) | A8 | |
| US6355243B1 | United States of America | B1 | |
| EP1232251A1 | European Patent Office (EPO) | A1 | |
| EP1232252A1 | European Patent Office (EPO) | A1 | |
| EP1232254A1 | European Patent Office (EPO) | A1 | |
| US2002192794A1 | United States of America | A1 | |
| US2003012778A1 | United States of America | A1 | |
| US2003026798A1 | United States of America | A1 | |
| JP2003514789A | Japan | A | |
| JP2003514790A | Japan | A | |
| US2003175264A1 | United States of America | A1 | |
| JP2003535574A | Japan | A | |
| WO2004037208A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003287221A1 | Australia | A1 | |
| AU2003287221A8 | Australia | A8 | |
| EP1232251A4 | European Patent Office (EPO) | A4 | |
| US2004171103A1 | United States of America | A1 | |
| WO2004037208A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1232252A4 | European Patent Office (EPO) | A4 | |
| EP1232254A4 | European Patent Office (EPO) | A4 | |
| US6964764B2 | United States of America | B2 | |
| US6969515B2 | United States of America | B2 | |
| AU784534B2 | Australia | B2 | |
| AU784598B2 | Australia | B2 | |
| AU784800B2 | Australia | B2 | |
| EP1232251B1 | European Patent Office (EPO) | B1 | |
| DE60036017D1 | Germany | D1 | |
| ES2290058T3 | Spain | T3 | |
| DE60036017T2 | Germany | T2 | |
| EP1956082A1 | European Patent Office (EPO) | A1 | |
| EP1232254B1 | European Patent Office (EPO) | B1 | |
| AT409222T | Austria | T | |
| ATE409222T1 | Austria | T1 | |
| DE60040345D1 | Germany | D1 | |
| DK1232254T3 | Denmark | T3 | |
| US2008311105A1 | United States of America | A1 | |
| PT1232254E | Portugal | E | |
| ES2313912T3 | Spain | T3 | |
| EP1232252B1 | European Patent Office (EPO) | B1 | |
| AT431401T | Austria | T | |
| ATE431401T1 | Austria | T1 | |
| US7544500B2 | United States of America | B2 | |
| PT1232252E | Portugal | E | |
| DE60042214D1 | Germany | D1 | |
| DK1232252T3 | Denmark | T3 | |
| ES2326616T3 | Spain | T3 | |
| US2009275513A1 | United States of America | A1 | |
| US7871608B2 | United States of America | B2 | |
| JP4988115B2 | Japan | B2 | |
| CA2389345C | Canada | C | |
| JP5025868B2 | Japan | B2 | |
| US8268782B2 | United States of America | B2 | |
| CA2389337C | Canada | C | |
| CA2389487C | Canada | C | |
| US2013164273A1 | United States of America | A1 | |
| US2013164815A1 | United States of America | A1 | |
| FR13C0041I1 | France | I1 | |
| LU92255I2This record | Luxembourg | I2 | |
| CY1108639T1 | Cyprus | T1 | |
| FR13C0041I2 | France | I2 | |
| CY1110516T1 | Cyprus | T1 | |
| CY2013030I1 | Cyprus | I1 | |
| CY2013030I2 | Cyprus | I2 | |
| NL300603I2 | Netherlands (Kingdom of the) | I2 | |
| EP1232251B2 | European Patent Office (EPO) | B2 | |
| ES2290058T5 | Spain | T5 | |
| DE60036017T3 | Germany | T3 | |
| US9879246B2 | United States of America | B2 | |
| BE2013C050I2 | Belgium | I2 |
Numbers
- Publication, DOCDB
- 92255
- Publication, EPODOC
- LU92255I
- Application
- 92255
- Application, DOCDB
- 92255
- Application, EPODOC
- LU20130092255C
Titles2
- English
- Ocriplasmin and its pharmaceutically acceptable derivatives (JETREA)
- French
- Ocriplasmine et ses dérivés pharmaceutiquement acceptables (JETREA)
Classification
- CPC, 14
- C12N9/6435
- A61K38/4833
- A61K38/484
- A61K47/02
- A61K47/12
- A61K47/183
- A61K47/26
- C12Y304/21007
- C12N9/99
- C12N9/96
- A61K47/20
- A61P7/02
- A61P9/10
- A61K45/06
- IPC, 18
- C12N9 99
- A61B17 00
- A61K9 19
- A61K38 00
- A61K38 48
- A61K47 02
- A61K47 10
- A61K47 12
- A61K47 18
- A61K47 22
- A61K47 26
- A61K47 36
- A61K47 42
- A61M25 00
- A61P7 02
- A61P9 10
- C12N9 68
- C12N9 96